| Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials RG Dos Santos, FS Guimarães, JAS Crippa, JEC Hallak, GN Rossi, ... Expert opinion on drug metabolism & toxicology 16 (6), 517-526, 2020 | 65 | 2020 |
| The use of classic hallucinogens/psychedelics in a therapeutic context: Healthcare policy opportunities and challenges RG Dos Santos, JC Bouso, JM Rocha, GN Rossi, JE Hallak Risk management and healthcare policy, 901-910, 2021 | 53 | 2021 |
| Ayahuasca improves self-perception of speech performance in subjects with social anxiety disorder: A pilot, proof-of-concept, randomized, placebo-controlled trial RG Dos Santos, F de Lima Osório, JM Rocha, GN Rossi, JC Bouso, ... Journal of clinical psychopharmacology 41 (5), 540-550, 2021 | 44 | 2021 |
| Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature JM Rocha, FL Osório, JAS Crippa, JC Bouso, GN Rossi, JEC Hallak, ... Therapeutic Advances in Psychopharmacology 9, 2045125319845774, 2019 | 44 | 2019 |
| Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial JM Rocha, GN Rossi, F de Lima Osório, JC Bouso, G de Oliveira Silveira, ... Journal of Clinical Psychopharmacology 41 (3), 267-274, 2021 | 30 | 2021 |
| Effects of ayahuasca and its alkaloids on substance use disorders: An updated (2016–2020) systematic review of preclinical and human studies LS Rodrigues, GN Rossi, JM Rocha, F L Osório, JC Bouso, JEC Hallak, ... European Archives of Psychiatry and Clinical Neuroscience 272 (4), 541-556, 2022 | 29 | 2022 |
| Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020–2022) JDR Souza, JC Pacheco, GN Rossi, BO de-Paulo, AW Zuardi, ... Pharmaceutics 14 (12), 2598, 2022 | 26 | 2022 |
| Stability evaluation of DMT and harmala alkaloids in ayahuasca tea samples G de Oliveira Silveira, R Guimarães dos Santos, F Rebello Lourenço, ... Molecules 25 (9), 2072, 2020 | 23 | 2020 |
| Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges GN Rossi, JEC Hallak, JC Bouso Saiz, RG Dos Santos Expert Opinion on Drug Safety 21 (6), 761-776, 2022 | 17 | 2022 |
| Effects of ayahuasca on personality: Results of two randomized, placebo-controlled trials in healthy volunteers J Mendes Rocha, GN Rossi, FL Osório, JC Bouso Saiz, GDO Silveira, ... Frontiers in psychiatry 12, 688439, 2021 | 17 | 2021 |
| Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study D Révész, G Ona, GN Rossi, JM Rocha, RG Dos Santos, JEC Hallak, ... Frontiers in psychiatry 12, 687546, 2021 | 17 | 2021 |
| The effects of Cannabidiol (CBD) and Delta-9-Tetrahydrocannabinol (THC) on the recognition of emotions in facial expressions: a systematic review of randomized controlled trials GN Rossi, FL Osório, CJA Morgan, JAS Crippa, JC Bouso, JM Rocha, ... Neuroscience & Biobehavioral Reviews 118, 236-246, 2020 | 15 | 2020 |
| Molecular pathways of the therapeutic effects of ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant GN Rossi, LTL Guerra, GB Baker, SM Dursun, JCB Saiz, JEC Hallak, ... Biomolecules 12 (11), 1618, 2022 | 13 | 2022 |
| Ayahuasca, a potentially rapid acting antidepressant: Focus on safety and tolerability GN Rossi, ICS Dias, G Baker, JC Bouso Saiz, SM Dursun, JEC Hallak, ... Expert Opinion on Drug Safety 21 (6), 789-801, 2022 | 12 | 2022 |
| Essential oil-based dispersive liquid-liquid microextraction for the determination of N, N-dimethyltryptamine and β-carbolines in human plasma: A novel solvent-free alternative G de Oliveira Silveira, FR Lourenço, AMF Pego, RG Dos Santos, ... Talanta 225, 121976, 2021 | 12 | 2021 |
| Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized … RG Dos Santos, JM Rocha, GN Rossi, FL Osório, G Ona, JC Bouso, ... Human Psychopharmacology: Clinical and Experimental 37 (4), e2834, 2022 | 11 | 2022 |
| Possible interactions between 5-HT2A receptors and the endocannabinoid system in humans: preliminary evidence of interactive effects of ayahuasca and endocannabinoids in a … RG Dos Santos, JA Crippa, F de Lima Osório, JM Rocha, GN Rossi, ... Journal of Clinical Psychopharmacology 38 (6), 644-646, 2018 | 10 | 2018 |
| L Osó rio F, Bouso JC, Hallak JEC, et al. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016 2020) systematic review of preclinical and human … LS Rodrigues, GN Rossi, JM Rocha Eur Arch Psychiatry Clin Neurosci 272 (4), 541-556, 2022 | 9 | 2022 |
| The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials GN Rossi, JEC Hallak, G Baker, SM Dursun, RG Dos Santos European Archives of Psychiatry and Clinical Neuroscience 273 (1), 129-155, 2023 | 8 | 2023 |
| Internet method for the extraction of N,N-dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine? GN Rossi, EJ Crevelin, G de Oliveira Silveira, M Eugênia Costa Queiroz, ... Journal of Psychedelic Studies 3 (1), 1-6, 2019 | 8 | 2019 |
Jaime E. HallakUniversidade de São Paulo在 fmrp.usp.br 的电子邮件经过验证
